New: the free Stackhaus Compass research dashboard, upload your labs
Skin & Anti-AgingAdvancedGray Area

Prostamax

Prostamax (Khavinson-School Synthetic Tetrapeptide, Lys-Glu-Asp-Pro)

Low Dose
No dosing established in the peer-reviewed literature
Medium Dose
No dosing established in the peer-reviewed literature; Russian OTC product labeling describes a short injectable course, not independently verified here
Route
SubQ / IM (per Russian product labeling; not derived from the cited research itself)
Cycle Length
No clinically established human protocol

Mechanism of Action

Synthetic tetrapeptide (Lys-Glu-Asp-Pro) from the Khavinson bioregulator family. Published work reports deheterochromatinization (decondensation of densely packed chromatin) in lymphocytes from elderly human subjects, proposed to release age-repressed genes, plus a stimulating effect on prostatic gland explants in organotypic rat tissue culture. The peptide-DNA interaction model is described in review literature but hasn't been independently validated at the receptor level — no well-characterized receptor and no human pharmacology data exist for how a free tetrapeptide reaches and acts on target cells.

Key Benefits

  • Chromatin decondensation / deheterochromatinization observed in aging human lymphocytes (ex vivo)
  • Stimulating effect on prostatic gland explants in young and aged rat organotypic tissue culture
  • Consistent findings across multiple Khavinson-group publications spanning two decades
  • No independent validation of the proposed prostate-specific clinical benefit in humans

Dosing Protocol

Low / Starting Dose
No dosing established in the peer-reviewed literature
Medium / Maintenance Dose
No dosing established in the peer-reviewed literature; Russian OTC product labeling describes a short injectable course, not independently verified here
Administration Route
SubQ / IM (per Russian product labeling; not derived from the cited research itself)
Half-Life
Not established — cited studies are in vitro/ex vivo, not human PK
Frequency
No clinically established human protocol
Cycle Length
No clinically established human protocol
Protocol Notes

Real literature exists here — six Khavinson-group papers spanning 2004–2017, including a rat prostatic-tissue study — which is a meaningfully different evidence picture than a compound with zero independent citations. But every cited study is ex vivo, in vitro, or animal tissue culture; none is a human prostate-health clinical trial. Present this compound on its actual evidence (epigenetic/chromatin research, prostate tissue-culture stimulation), not on unverified prostatitis/BPH treatment claims repeated across vendor sites.

Calculate reconstitution & draw for Prostamax

Ideal Candidates

Research contexts modeling chromatin/epigenetic aging or the Khavinson bioregulator peptide class specifically. Not supported by any human clinical trial for prostate health — the existing literature is ex vivo/tissue-culture, not a treatment study.

Side Effects & Safety

No human clinical safety data exists in the cited literature.

Regulatory Status

Gray Area

Not on the 503A bulks list. Gray zone — sold as a supplement in Russia. Part of the Khavinson-school bioregulator peptide family, the same research tradition as Epitalon and Thymalin already in this library.

Frequently asked

What is Prostamax?+

Prostamax (Prostamax (Khavinson-School Synthetic Tetrapeptide, Lys-Glu-Asp-Pro)) is a peptide studied for khavinson bioregulator and chromatin/epigenetic research. Synthetic tetrapeptide (Lys-Glu-Asp-Pro) from the Khavinson bioregulator family. Published work reports deheterochromatinization (decondensation of densely packed chromatin) in lymphocytes from elderly human subjects, proposed to release age-repressed genes, plus a stimulating effect on prostatic gland explants in organotypic rat tissue culture. The peptide-DNA interaction model is described in review literature but hasn't been independently validated at the receptor level — no well-characterized receptor and no human pharmacology data exist for how a free tetrapeptide reaches and acts on target cells.

What is the dosing protocol for Prostamax?+

Literature commonly references No dosing established in the peer-reviewed literature (low) to No dosing established in the peer-reviewed literature; Russian OTC product labeling describes a short injectable course, not independently verified here (maintenance) via SubQ / IM (per Russian product labeling; not derived from the cited research itself), on a no clinically established human protocol cycle. Educational reference only — a licensed Stackhaus Health provider sets any personalized protocol.

What is the regulatory status of Prostamax?+

Not on the 503A bulks list. Gray zone — sold as a supplement in Russia. Part of the Khavinson-school bioregulator peptide family, the same research tradition as Epitalon and Thymalin already in this library.

Where can I access Prostamax?+

Research-grade Prostamax is available through Stackhaus Research. For a personalized, provider-reviewed protocol, consult a licensed clinician through Stackhaus Health.

More in Skin & Anti-Aging

Written and reviewed by Stackhaus Academy Editorial Team · Last reviewed July 2026

Educational Only. This page is educational reference material, not medical advice. It does not establish a doctor-patient relationship and is not a substitute for individualized clinical guidance. Personalized protocols and clinical decisions are made through a licensed provider via Stackhaus Health.